{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:05:21Z","timestamp":1768280721958,"version":"3.49.0"},"reference-count":120,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>&lt;p&gt;The current global epidemic of hypertension is not a disease in and of itself but rather\na significant risk factor for serious cardiovascular conditions such as peripheral artery disease,\nheart failure, myocardial infarction, and stroke. Although many medications that work through\nvarious mechanisms of action are available on the market in conventional formulations to treat\nhypertension, these medications face significant difficulties with their bioavailability, dosing,\nand associated side effects, which significantly reduces the effectiveness of their therapeutic\ninterventions. Numerous studies have shown that nanocarriers and nanoformulations can minimize\nthe toxicity associated with high doses of the drug while greatly increasing the drug's bioavailability\nand reducing the frequency of dosing.\n&lt;\/p&gt;\n&lt;p&gt;\nThis review sheds light on the difficulties posed by traditional antihypertensive formulations and\nhighlights the necessity of oral nanoparticulate systems to solve these issues. Because hypertension\nhas a circadian blood pressure pattern, chronotherapeutics can be very important in treating\nthe condition. On the other hand, nanoparticulate systems can be very important in managing\nhypertension.&lt;\/p&gt;<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892010291414240322112508","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T05:12:40Z","timestamp":1712121160000},"page":"169-185","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Comprehensive Review on Nanoparticles as Drug Delivery System and Their Role for Management of Hypertension"],"prefix":"10.2174","volume":"26","author":[{"family":"Prerna","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University) Mullana, Ambala, 133207, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh Chandra","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Jambheswar University of\nSciences and Technology, Hisar, Haryana, 125001, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid Basir","family":"Mir","sequence":"additional","affiliation":[{"name":"School of Medical and Allied Sciences, K. R. Mangalam\nUniversity, Sohna Road, Gurgaon, Haryana, 122103, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikash","family":"Kumar","sequence":"additional","affiliation":[{"name":"DK Pharma College, Dhani T. Bad, Rewari, Haryana,\n123411, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Rathor","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University)\nMullana, Ambala, 133207, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/10717544.2016.1255999","volume":"24","author":"Alam T.","year":"2017","unstructured":"Alam T.; Khan S.; Gaba B.; Haider M.F.; Baboota S.; Ali J.; Nanocarriers as treatment modalities for hypertension. Drug Deliv  2017,24(1),358-369","journal-title":"Drug Deliv"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11906-019-0949-4","volume":"21","author":"Kitt J.","year":"2019","unstructured":"Kitt J.; Fox R.; Tucker K.L.; McManus R.J.; New approaches in hypertension management: A review of current and developing technologies and their potential impact on hypertension care. Curr Hypertens Rep  2019,21(6),44","journal-title":"Curr Hypertens Rep"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.3390\/molecules24152710","volume":"24","author":"Pechanova O.","year":"2019","unstructured":"Pechanova O.; Barta A.; Koneracka M.; Zavisova V.; Kubovcikova M.; Klimentova J.; T\u04e7r\u04e7k J.; Zemancikova A.; Cebova M.; Protective effects of nanoparticle-loaded aliskiren on cardiovascular system in spontaneously hypertensive rats. Molecules  2019,24(15),2710","journal-title":"Molecules"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/HYP.0000000000000003","volume":"63","author":"Go A.S.","year":"2014","unstructured":"Go A.S.; Bauman M.A.; Coleman King S.M.; Fonarow G.C.; Lawrence W.; Williams K.A.; Sanchez E.; An effective approach to high blood pressure control: A science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension  2014,63(4),878-885","journal-title":"Hypertension"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1016\/j.amepre.2017.06.020","volume":"53","author":"Park C.","year":"2017","unstructured":"Park C.; Wang G.; Durthaler J.M.; Fang J.; Cost-effectiveness analyses of antihypertensive medicines: A systematic review. Am J Prev Med  2017,53(6),S131-S142","journal-title":"Am J Prev Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"CD008276","DOI":"10.1002\/14651858.CD008276.pub2","volume":"2017","author":"Musini V.M.","year":"2017","unstructured":"Musini V.M.; Gueyffier F.; Puil L.; Salzwedel D.M.; Wright J.M.; Pharmacotherapy for hypertension in adults aged 18 to 59 years. Cochrane Libr  2017,2017(8),CD008276","journal-title":"Cochrane Libr"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrcardio.2010.85","volume":"7","author":"Paulis L.","year":"2010","unstructured":"Paulis L.; Unger T.; Novel therapeutic targets for hypertension. Nat Rev Cardiol  2010,7(8),431-441","journal-title":"Nat Rev Cardiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/jcm6060061","volume":"6","author":"Pantzaris N.D.","year":"2017","unstructured":"Pantzaris N.D.; Karanikolas E.; Tsiotsios K.; Velissaris D.; Renin inhibition with aliskiren: A decade of clinical experience. J Clin Med  2017,6(6),61","journal-title":"J Clin Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"CD007066","DOI":"10.1002\/14651858.CD007066.pub3","volume":"2017","author":"Musini V.M.","year":"2017","unstructured":"Musini V.M.; Lawrence K.A.K.; Fortin P.M.; Bassett K.; Wright J.M.; Blood pressure lowering efficacy of renin inhibitors for primary hypertension. Cochrane Libr  2017,2017(4),CD007066","journal-title":"Cochrane Libr"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4103\/2249-4863.154630","volume":"4","author":"Yaxley J.","year":"2015","unstructured":"Yaxley J.; Thambar S.; Resistant hypertension: An approach to management in primary care. J Family Med Prim Care  2015,4(2),193-199","journal-title":"J Family Med Prim Care"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1753944718773690","volume":"12","author":"Mart\u00edn Gim\u00e9nez V.M.","year":"2018","unstructured":"Mart\u00edn Gim\u00e9nez V.M.; Noriega S.E.; Kassuha D.E.; Fuentes L.B.; Manucha W.; Anandamide and endocannabinoid system: An attractive therapeutic approach for cardiovascular disease. Ther Adv Cardiovasc Dis  2018,12(7),177-190","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"ref=12","first-page":"439","volume":"27","author":"Taylor D.A.","year":"2015","unstructured":"Taylor D.A.; Hypertensive crisis: A review of pathophysiology and treatment. Critical Care Nursing Clinics  2015,27(4),439-447","journal-title":"Critical Care Nursing Clinics"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3109\/08037051.2010.488052","volume":"19","author":"Papadopoulos D.P.","year":"2010","unstructured":"Papadopoulos D.P.; Mourouzis I.; Thomopoulos C.; Makris T.; Papademetriou V.; Hypertension crisis. Blood Press  2010,19(6),328-336","journal-title":"Blood Press"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/HJH.0b013e328345023d","volume":"29","author":"van den Born B.J.H.","year":"2011","unstructured":"van den Born B.J.H.; L\u00f6wenberg E.C.; van der Hoeven N.V.; de Laat B.; Meijers J.C.M.; Levi M.; van Montfrans G.A.; Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis. J Hypertens  2011,29(5),922-927","journal-title":"J Hypertens"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/bmj.298.6673.564","volume":"298","author":"Barker D.J.","year":"1989","unstructured":"Barker D.J.; Osmond C.; Golding J.; Kuh D.; Wadsworth M.E.; Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ  1989,298(6673),564-567","journal-title":"BMJ"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/ije\/dyz078","volume":"49","author":"Ng R.","year":"2020","unstructured":"Ng R.; Sutradhar R.; Yao Z.; Wodchis W.P.; Rosella L.C.; Smoking, drinking, diet and physical activity\u2014modifiable lifestyle risk factors and their associations with age to first chronic disease. Int J Epidemiol  2020,49(1),113-130","journal-title":"Int J Epidemiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1136\/bmj.322.7291.912","volume":"322","author":"Beevers G.","year":"2001","unstructured":"Beevers G.; Lip G.Y.; O\u2019Brien E.; ABC of hypertension: The pathophysiology of hypertension. BMJ  2001,322(7291),912-916","journal-title":"BMJ"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/13576280310001607596","volume":"16","author":"Guilbert J.J.","year":"2003","unstructured":"Guilbert J.J.; The world health report 2002 - reducing risks, promoting healthy life. Educ Health  2003,16(2),230","journal-title":"Educ Health"},{"key":"ref=19","year":"2005","unstructured":"Preventing chronic diseases: A vital investment; World Health Organization  2005","journal-title":"A vital investment; World Health Organization"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/S0140-6736(03)12918-2","volume":"361","author":"Anselmi M.","year":"2003","unstructured":"Anselmi M.; Avanzini F.; More\u00edra J.M.; Montalvo G.; Armani D.; Prandi R.; Marquez M.; Caicedo C.; Colombo F.; Tognoni G.; Treatment and control of arterial hypertension in a rural community in Ecuador. Lancet  2003,361(9364),1186-1187","journal-title":"Lancet"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","volume":"365","author":"Kearney P.M.","year":"2005","unstructured":"Kearney P.M.; Whelton M.; Reynolds K.; Muntner P.; Whelton P.K.; He J.; Global burden of hypertension: Analysis of worldwide data. Lancet  2005,365(9455),217-223","journal-title":"Lancet"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/00004872-200018050-00003","volume":"18","author":"Fuentes R.","year":"2000","unstructured":"Fuentes R.; Ilmaniemi N.; Laurikainen E.; Tuomilehto J.; Nissinen A.; Hypertension in developing economies. J Hypertens  2000,18(5),521-529","journal-title":"J Hypertens"},{"key":"ref=23","first-page":"4","volume":"18","author":"Mayosi B.","year":"2007","unstructured":"Mayosi B.; A statement of intent on the formation of the NCRP on cardiovascular and metabolic disease: A new initiative to fight heart disease, stroke, diabetes and obesity in South Africa. Cardiovasc J S Afr  2007,18(1),4-6","journal-title":"Cardiovasc J S Afr"},{"key":"ref=24","first-page":"99","volume":"54","author":"Padmavati S.","year":"2002","unstructured":"Padmavati S.; Prevention of heart disease in India in the 21st century: need for a concerted effort. Indian Heart J  2002,54(1),99-102","journal-title":"Indian Heart J"},{"key":"ref=25","first-page":"E174","volume":"122","author":"Tran J.","year":"2010","unstructured":"Tran J.; Mirzaei M.; Leeder S.; Hypertension: its prevalence and population-attributable fraction for mortality from stroke in the Middle East and north Africa. InCirculation  2010,122,E174-E174","journal-title":"InCirculation"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1001\/jama.291.21.2616","volume":"291","author":"Yach D.","year":"2004","unstructured":"Yach D.; Hawkes C.; Gould C.L.; Hofman K.J.; The global burden of chronic diseases: Overcoming impediments to prevention and control. JAMA  2004,291(21),2616-2622","journal-title":"JAMA"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.107.095497","volume":"50","author":"Perkovic V.","year":"2007","unstructured":"Perkovic V.; Huxley R.; Wu Y.; Prabhakaran D.; MacMahon S.; The burden of blood pressure-related disease: A neglected priority for global health. Hypertension  2007,50(6),991-997","journal-title":"Hypertension"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/0973-7847.79097","volume":"5","author":"Tabassum N.","year":"2011","unstructured":"Tabassum N.; Ahmad F.; Role of natural herbs in the treatment of hypertension. Pharmacogn Rev  2011,5(9),30-40","journal-title":"Pharmacogn Rev"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1211\/0022357022917","volume":"56","author":"Hasrat J.A.","year":"2010","unstructured":"Hasrat J.A.; Pieters L.; Vlietinck A.J.; Medicinal plants in Suriname: Hypotensive effect of Gossypium barbadense. J Pharm Pharmacol  2010,56(3),381-387","journal-title":"J Pharm Pharmacol"},{"key":"ref=30","first-page":"12","volume":"3","author":"Bawa R.","year":"2009","unstructured":"Bawa R.; Nanopharmaceuticals for drug delivery\u2014A review. Drug Deliv  2009,3(122127),12","journal-title":"Drug Deliv"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.drudis.2007.10.021","volume":"13","author":"Sahoo S.","year":"2008","unstructured":"Sahoo S.; Dilnawaz F.; Krishnakumar S.; Nanotechnology in ocular drug delivery. Drug Discov Today  2008,13(3-4),144-151","journal-title":"Drug Discov Today"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2011.01.007","volume":"78","author":"M\u00fcller R.H.","year":"2011","unstructured":"M\u00fcller R.H.; Gohla S.; Keck C.M.; State of the art of nanocrystals \u2013 Special features, production, nanotoxicology aspects and intracellular delivery. Eur J Pharm Biopharm  2011,78(1),1-9","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1943089213506978","volume":"1","author":"Nasimi P.","year":"2013","unstructured":"Nasimi P.; Haidari M.; Medical use of nanoparticles: Drug delivery and diagnosis diseases. Int J Green Nanotechnol  2013,1,1-5","journal-title":"Int J Green Nanotechnol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/IJN.S596","volume":"3","author":"de Jong W.H.","year":"2008","unstructured":"de Jong W.H.; Borm P.J.; Drug delivery and nanoparticles: Applications and hazards. Int J Nanomedicine  2008,3(2),133-149","journal-title":"Int J Nanomedicine"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/cmdc.201700322","volume":"12","author":"Iacobazzi R.M.","year":"2017","unstructured":"Iacobazzi R.M.; Lopalco A.; Cutrignelli A.; Laquintana V.; Lopedota A.; Franco M.; Denora N.; Bridging pharmaceutical chemistry with drug and nanoparticle targeting to investigate the role of the 18\u2010kDa translocator protein TSPO. ChemMedChem  2017,12(16),1261-1274","journal-title":"ChemMedChem"},{"key":"ref=36","first-page":"1985","volume":"10","author":"Lopalco A.","year":"2015","unstructured":"Lopalco A.; Ali H.; Denora N.; Rytting E.; Oxcarbazepine-loaded polymeric nanoparticles: Development and permeability studies across in vitro models of the blood-brain barrier and human placental trophoblast. Int J Nanomedicine  2015,10,1985-1996","journal-title":"Int J Nanomedicine"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.jconrel.2013.09.024","volume":"172","author":"Denora N.","year":"2013","unstructured":"Denora N.; Laquintana V.; Lopalco A.; Iacobazzi R.M.; Lopedota A.; Cutrignelli A.; Iacobellis G.; Annese C.; Cascione M.; Leporatti S.; Franco M.; In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM\u2013FITC labeled dendrimer. J Control Release  2013,172(3),1111-1125","journal-title":"J Control Release"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.actbio.2016.07.025","volume":"43","author":"Denora N.","year":"2016","unstructured":"Denora N.; Lopedota A.; Perrone M.; Laquintana V.; Iacobazzi R.M.; Milella A.; Fanizza E.; Depalo N.; Cutrignelli A.; Lopalco A.; Franco M.; Spray-dried mucoadhesives for intravesical drug delivery using N-acetylcysteine- and glutathione-glycol chitosan conjugates. Acta Biomater  2016,43,170-184","journal-title":"Acta Biomater"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1021\/mp400536z","volume":"11","author":"Laquintana V.","year":"2014","unstructured":"Laquintana V.; Denora N.; Lopalco A.; Lopedota A.; Cutrignelli A.; Lasorsa F.M.; Agostino G.; Franco M.; Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Mol Pharm  2014,11(3),859-871","journal-title":"Mol Pharm"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ijpharm.2017.06.049","volume":"528","author":"Iacobazzi R.M.","year":"2017","unstructured":"Iacobazzi R.M.; Porcelli L.; Lopedota A.A.; Laquintana V.; Lopalco A.; Cutrignelli A.; Altamura E.; Di Fonte R.; Azzariti A.; Franco M.; Denora N.; Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers. Int J Pharm  2017,528(1-2),485-497","journal-title":"Int J Pharm"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"app.39694","DOI":"10.1002\/app.39694","volume":"131","author":"Varshosaz J.","year":"2014","unstructured":"Varshosaz J.; Taymouri S.; Hamishehkar H.; Fabrication of polymeric nanoparticles of poly(ethylene\u2010 co \u2010vinyl acetate) coated with chitosan for pulmonary delivery of carvedilol. J Appl Polym Sci  2014,131(1),app.39694","journal-title":"J Appl Polym Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1773-2247(14)50126-8","volume":"24","author":"Javed I.","year":"2014","unstructured":"Javed I.; Ranjha N.M.; Mahmood K.; Kashif S.; Rehman M.; Usman F.; Drug release optimization from microparticles of poly(E-caprolactone) and hydroxypropyl methylcellulose polymeric blends: formulation and characterization. J Drug Deliv Sci Technol  2014,24(6),607-612","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.4314\/tjpr.v20i6.1","volume":"20","author":"Moeed A.","year":"2022","unstructured":"Moeed A.; Khalid A.; Bashir S.; Bashir H.; Al Kahraman Y.M.S.A.; Ismail T.; Amirzada M.I.; Verapamil hydrochloride nanoparticles formulated with chitosan and sodium alginate by an ionic gelation method. Trop J Pharm Res  2022,20(6),1105-1111","journal-title":"Trop J Pharm Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40580-014-0031-5","volume":"1","author":"Jana U.","year":"2014","unstructured":"Jana U.; Mohanty A.K.; Pal S.L.; Manna P.K.; Mohanta G.P.; Felodipine loaded PLGA nanoparticles: Preparation, physicochemical characterization and in vivo toxicity study. Nano Converg  2014,1(1),31","journal-title":"Nano Converg"},{"key":"ref=45","first-page":"177","volume":"64","author":"Silva A.C.","year":"2009","unstructured":"Silva A.C.; Santos D.; Ferreira D.C.; Souto E.B.; Minoxidil-loaded nanostructured lipid carriers (NLC): Characterization and rheological behaviour of topical formulations. Pharmazie  2009,64(3),177-182","journal-title":"Pharmazie"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1166\/jnn.2006.474","volume":"6","author":"Tamayo-Esquivel D.","year":"2006","unstructured":"Tamayo-Esquivel D.; Ganem-Quintanar A.; Mart\u00ednez A.L.; Navarrete-Rodr\u00edguez M.; Rodr\u00edguez-Romo S.; Quintanar-Guerrero D.; Evaluation of the enhanced oral effect of omapatrilat-monolein nanoparticles prepared by the emulsification-diffusion method. J Nanosci Nanotechnol  2006,6(9),3134-3138","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"314","DOI":"10.5530\/jyp.2020.12.84","volume":"12","author":"Uthaman M.","year":"2020","unstructured":"Uthaman M.; Koland M.; Investigation of polymeric micellar nanoparticles of amlodipine besylatefor transdermal delivery. J Young Pharm  2020,12(4),314-320","journal-title":"J Young Pharm"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/1061186X.2019.1650053","volume":"28","author":"Aboud H.M.","year":"2020","unstructured":"Aboud H.M.; Mahmoud M.O.; Abdeltawab Mohammed M.; Shafiq Awad M.; Sabry D.; Preparation and appraisal of self-assembled valsartan-loaded amalgamated Pluronic F127\/Tween 80 polymeric micelles: Boosted cardioprotection via regulation of Mhrt\/Nrf2 and Trx1 pathways in cisplatin-induced cardiotoxicity. J Drug Target  2020,28(3),282-299","journal-title":"J Drug Target"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.nano.2011.06.004","volume":"8","author":"Ahad A.","year":"2012","unstructured":"Ahad A.; Aqil M.; Kohli K.; Sultana Y.; Mujeeb M.; Ali A.; Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomedicine  2012,8(2),237-249","journal-title":"Nanomedicine"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.colsurfb.2018.02.011","volume":"165","author":"Pandya N.T.","year":"2018","unstructured":"Pandya N.T.; Jani P.; Vanza J.; Tandel H.; Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension. Colloids Surf B Biointerfaces  2018,165,37-44","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=51","first-page":"1","author":"Paliwal S.","year":"2023","unstructured":"Paliwal S.; Sharma J.; Dave V.; Sharma S.; Verma K.; Tak K.; Kakarla R.R.; Sadhu V.; Walvekar P.; Aminabhavi T.M.; Novel biocompatible polymer-modified liposome nanoparticles for biomedical applications. Polym Bull  2023,1-3","journal-title":"Polym Bull"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/03639045.2020.1724128","volume":"46","author":"Mundada V.P.","year":"2020","unstructured":"Mundada V.P.; Patel M.H.; Mundada P.K.; Sawant K.K.; Enhanced bioavailability and antihypertensive activity of nisoldipine loaded nanoemulsion: optimization, cytotoxicity and uptake across Caco-2 cell line, pharmacokinetic and pharmacodynamic studies. Drug Dev Ind Pharm  2020,46(3),376-387","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jddst.2018.03.014","volume":"45","author":"\u00d6zdemir S.","year":"2018","unstructured":"\u00d6zdemir S.; \u00c7elik B.; S\u00fcmer E.; Acar E.T.; \u00dcner M.; Eplerenone nanoemulsions for treatment of hypertension. Part II: Physical stability assessment and in vivo study. J Drug Deliv Sci Technol  2018,45,287-295","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1556-276X-9-247","volume":"9","author":"Abbasi E.","year":"2014","unstructured":"Abbasi E.; Aval S.F.; Akbarzadeh A.; Milani M.; Nasrabadi H.T.; Joo S.W.; Hanifehpour Y.; Nejati-Koshki K.; Pashaei-Asl R.; Dendrimers: Synthesis, applications, and properties. Nanoscale Res Lett  2014,9(1),247","journal-title":"Nanoscale Res Lett"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1073\/pnas.082013899","volume":"99","author":"Fr\u00e9chet J.M.J.","year":"2002","unstructured":"Fr\u00e9chet J.M.J.; Dendrimers and supramolecular chemistry. Proc Natl Acad Sci USA  2002,99(8),4782-4787","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=56","author":"Umoren S.A.","year":"2022","unstructured":"Umoren S.A.; Solomon M.M.;  Saji, VS Polymeric Materials in Corrosion Inhibition: Fundamentals and Applications  2022","journal-title":"Saji, VS Polymeric Materials in Corrosion Inhibition: Fundamentals and Applications"},{"key":"ref=57","doi-asserted-by":"publisher","DOI":"10.1201\/b22463","author":"Sharma A.K.","year":"2018","unstructured":"Sharma A.K.; Keservani R.K.;  Eds; Dendrimers for drug delivery  2018","journal-title":"Eds; Dendrimers for drug delivery"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/pol.20200721","volume":"59","author":"Smith R.J.","year":"2021","unstructured":"Smith R.J.; Gorman C.; Menegatti S.; Synthesis, structure, and function of internally functionalized dendrimers. J Polym Sci  2021,59(1),10-28","journal-title":"J Polym Sci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/nbt1171","volume":"23","author":"Lee C.C.","year":"2005","unstructured":"Lee C.C.; MacKay J.A.; Fr\u00e9chet J.M.J.; Szoka F.C.; Designing dendrimers for biological applications. Nat Biotechnol  2005,23(12),1517-1526","journal-title":"Nat Biotechnol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/B978-0-12-818433-2.00003-0","author":"Krug P.","year":"2019","unstructured":"Krug P.; Bartel M.; G\u0142owala P.; Wysocka B.; Mojzych I.; Kwiatkowska M.; Skiba A.; W\u00f3jtowicz A.; Mazur M.;  In: Materials for Biomedical Engineering  2019,59-111","journal-title":"In: Materials for Biomedical Engineering"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"11630","DOI":"10.1007\/s10853-022-07289-3","volume":"57","author":"Perumal S.","year":"2022","unstructured":"Perumal S.; Atchudan R.; Ramalingam S.; Edison T.N.J.I.; Lee H.M.; Cheong I.W.; Devarajan N.; Lee Y.R.; Comparative investigation on antibacterial studies of Oxalis corniculata and silver nanoparticle stabilized graphene surface. J Mater Sci  2022,57(25),11630-11648","journal-title":"J Mater Sci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"601626","DOI":"10.3389\/fphar.2021.601626","volume":"12","author":"Gagliardi A.","year":"2021","unstructured":"Gagliardi A.; Giuliano E.; Venkateswararao E.; Fresta M.; Bulotta S.; Awasthi V.; Cosco D.; Biodegradable polymeric nanoparticles for drug delivery to solid tumors. Front Pharmacol  2021,12,601626","journal-title":"Front Pharmacol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.3390\/polym14245449","volume":"14","author":"Perumal S.","year":"2022","unstructured":"Perumal S.; Polymer nanoparticles: Synthesis and applications. Polymers  2022,14(24),5449","journal-title":"Polymers"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3390\/nano10071403","volume":"10","author":"Begines B.","year":"2020","unstructured":"Begines B.; Ortiz T.; P\u00e9rez-Aranda M.; Mart\u00ednez G.; Merinero M.; Arg\u00fcelles-Arias F.; Alcudia A.; Polymeric nanoparticles for drug delivery: Recent developments and future prospects. Nanomaterials  2020,10(7),1403","journal-title":"Nanomaterials"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/1061186X.2019.1588280","volume":"27","author":"Vauthier C.","year":"2019","unstructured":"Vauthier C.; A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles. J Drug Target  2019,27(5-6),502-524","journal-title":"J Drug Target"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"Akbarzadeh A.","year":"2013","unstructured":"Akbarzadeh A.; Rezaei-Sadabady R.; Davaran S.; Joo S.W.; Zarghami N.; Hanifehpour Y.; Samiei M.; Kouhi M.; Nejati-Koshki K.; Liposome: Classification, preparation, and applications. Nanoscale Res Lett  2013,8(1),102","journal-title":"Nanoscale Res Lett"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.addr.2012.09.031","volume":"64","author":"Torchilin V.P.","year":"2012","unstructured":"Torchilin V.P.; Multifunctional nanocarriers. Adv Drug Deliv Rev  2012,64,302-315","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"113851","DOI":"10.1016\/j.addr.2021.113851","volume":"176","author":"Large D.E.","year":"2021","unstructured":"Large D.E.; Abdelmessih R.G.; Fink E.A.; Auguste D.T.; Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev  2021,176,113851","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.3390\/ijms22126547","volume":"22","author":"\u0160turm L.","year":"2021","unstructured":"\u0160turm L.; Poklar Ulrih N.; Basic methods for preparation of liposomes and studying their interactions with different compounds, with the emphasis on polyphenols. Int J Mol Sci  2021,22(12),6547","journal-title":"Int J Mol Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1038\/s41467-020-17863-5","volume":"11","author":"Blanken D.","year":"2020","unstructured":"Blanken D.; Foschepoth D.; Serr\u00e3o A.C.; Danelon C.; Genetically controlled membrane synthesis in liposomes. Nat Commun  2020,11(1),4317","journal-title":"Nat Commun"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.2147\/IJN.S203330","volume":"14","author":"Lujan H.","year":"2019","unstructured":"Lujan H.; Griffin W.C.; Taube J.H.; Sayes C.M.; Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells. Int J Nanomedicine  2019,14,5159-5173","journal-title":"Int J Nanomedicine"},{"key":"ref=72","doi-asserted-by":"publisher","DOI":"10.5772\/58422","author":"Bennet D.","year":"2014","unstructured":"Bennet D.; Kim S.;  In: Application of Nanotechnology in Drug Delivery  2014","journal-title":"In: Application of Nanotechnology in Drug Delivery"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"Nsairat H.","year":"2022","unstructured":"Nsairat H.; Khater D.; Sayed U.; Odeh F.; Al Bawab A.; Alshaer W.; Liposomes: Structure, composition, types, and clinical applications. Heliyon  2022,8(5),e09394","journal-title":"Heliyon"},{"key":"ref=74","first-page":"341","volume":"53","author":"Couvreur P.","year":"1978","unstructured":"Couvreur P.; Kante B.; Roland M.; Perspective on the use of microdisperse forms as intracellular vehicles. Pharm Acta Helv  1978,53(12),341-347","journal-title":"Pharm Acta Helv"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1021\/ma9027257","volume":"43","author":"Mu\u00f1oz-Bonilla A.","year":"2010","unstructured":"Mu\u00f1oz-Bonilla A.; van Herk A.M.; Heuts J.P.A.; Preparation of hairy particles and antifouling films using brush-type amphiphilic block copolymer surfactants in emulsion polymerization. Macromolecules  2010,43(6),2721-2731","journal-title":"Macromolecules"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.matlet.2008.12.045","volume":"63","author":"Lu S.","year":"2009","unstructured":"Lu S.; Qu R.; Forcada J.; Preparation of magnetic polymeric composite nanoparticles by seeded emulsion polymerization. Mater Lett  2009,63(9-10),770-772","journal-title":"Mater Lett"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.msec.2008.08.013","volume":"29","author":"Costa C.","year":"2009","unstructured":"Costa C.; Santos A.F.; Fortuny M.; Ara\u00fajo P.H.H.; Sayer C.; Kinetic advantages of using microwaves in the emulsion polymerization of MMA. Mater Sci Eng C  2009,29(2),415-419","journal-title":"Mater Sci Eng C"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1002\/pola.21472","volume":"44","author":"Cheng X.","year":"2006","unstructured":"Cheng X.; Chen M.; Zhou S.; Wu L.; Preparation of SiO 2\/PMMA composite particles via conventional emulsion polymerization. J Polym Sci A Polym Chem  2006,44(12),3807-3816","journal-title":"J Polym Sci A Polym Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.synthmet.2008.11.011","volume":"159","author":"Yoon S.J.","year":"2009","unstructured":"Yoon S.J.; Chun H.; Lee M.S.; Kim N.; Preparation of poly(N-vinylcarbazole) (PVK) nanoparticles by emulsion polymerization and PVK hollow particles. Synth Met  2009,159(5-6),518-522","journal-title":"Synth Met"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1111\/j.2042-7158.1986.tb04547.x","volume":"38","author":"el-Samaligy M.","year":"1986","unstructured":"el-Samaligy M.; Rohdewald P.; Mahmoud H.; Polyalkyl cyanoacrylate nanocapsules. J Pharm Pharmacol  1986,38(3),e216-e218","journal-title":"J Pharm Pharmacol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0168-3659(98)00078-9","volume":"56","author":"Kriwet B.","year":"1998","unstructured":"Kriwet B.; Walter E.; Kissel T.; Synthesis of bioadhesive poly(acrylic acid) nano- and microparticles using an inverse emulsion polymerization method for the entrapment of hydrophilic drug candidates. J Control Release  1998,56(1-3),149-158","journal-title":"J Control Release"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1021\/ma991782n","volume":"33","author":"Landfester K.","year":"2000","unstructured":"Landfester K.; Willert M.; Antonietti M.; Preparation of polymer particles in nonaqueous direct and inverse miniemulsions. Macromolecules  2000,33(7),2370-2376","journal-title":"Macromolecules"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.biochi.2016.07.008","volume":"128-129","author":"Jeevanandam J.","year":"2016","unstructured":"Jeevanandam J.; Chan Y.S.; Danquah M.K.; Nano-formulations of drugs: Recent developments, impact and challenges. Biochimie  2016,128-129,99-112","journal-title":"Biochimie"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cis.2017.07.002","volume":"247","author":"Kim H.S.","year":"2017","unstructured":"Kim H.S.; Mason T.G.; Advances and challenges in the rheology of concentrated emulsions and nanoemulsions. Adv Colloid Interface Sci  2017,247,397-412","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11998-004-0026-y","author":"Landfester K","year":"2004","unstructured":"Landfester K; Eisenbl\u00e4tter J; Rothe R; Preparation of polymerizable miniemulsions by ultrasonication. JCT research  2004,65-68","journal-title":"JCT research"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.colsurfa.2004.04.070","volume":"242","author":"Vangeyte P.","year":"2004","unstructured":"Vangeyte P.; Gautier S.; J\u00e9r\u00f4me R.; About the methods of preparation of poly(ethylene oxide)-b-poly(\u03b5-caprolactone) nanoparticles in water. Colloids Surf A Physicochem Eng Asp  2004,242(1-3),203-211","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i1.10","volume":"19","author":"Kabanov A.V.","year":"2002","unstructured":"Kabanov A.V.; Alakhov V.Y.; Pluronic block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst  2002,19(1),1-72","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0378-5173(95)04386-1","volume":"132","author":"Zhang X.","year":"1996","unstructured":"Zhang X.; Jackson J.K.; Burt H.M.; Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm  1996,132(1-2),195-206","journal-title":"Int J Pharm"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0927-7765(99)00067-3","volume":"16","author":"Burt H.M.","year":"1999","unstructured":"Burt H.M.; Zhang X.; Toleikis P.; Embree L.; Hunter W.L.; Development of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloids Surf B Biointerfaces  1999,16(1-4),161-171","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/jps.10533","volume":"93","author":"Liu J.","year":"2004","unstructured":"Liu J.; Xiao Y.; Allen C.; Polymer\u2013drug compatibility: A guide to the development of delivery systems for the anticancer agent, ellipticine. J Pharm Sci  2004,93(1),132-143","journal-title":"J Pharm Sci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0168-3659(97)00124-7","volume":"51","author":"Kim S.Y.","year":"1998","unstructured":"Kim S.Y.; Shin I.L.G.; Lee Y.M.; Cho C.S.; Sung Y.K.; Methoxy poly(ethylene glycol) and \u03f5-caprolactone amphiphilic block copolymeric micelle containing indomethacin. J Control Release  1998,51(1),13-22","journal-title":"J Control Release"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1023\/B:PHAM.0000036917.75634.be","volume":"21","author":"Galindo-Rodriguez S.","year":"2004","unstructured":"Galindo-Rodriguez S.; All\u00e9mann E.; Fessi H.; Doelker E.; Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res  2004,21(8),1428-1439","journal-title":"Pharm Res"},{"key":"ref=93","first-page":"263","volume":"5","author":"Rathor S.","year":"2017","unstructured":"Rathor S.; Bhatt D.C.; Aamir S.; Singh S.K.; Kumar V.; A comprehensive review on role of nanoparticles in therapeutic delivery of medicine. Pharm Nanotechnol  2017,5(4),263-275","journal-title":"Pharm Nanotechnol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.2174\/1381612822666160217125734","volume":"22","author":"Kaur H.","year":"2016","unstructured":"Kaur H.; Kumar V.; Kumar K.; Rathor S.; Kumari P.; Singh J.; Polymer particulates in drug delivery. Curr Pharm Des  2016,22(19),2761-2787","journal-title":"Curr Pharm Des"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"e080121190007","DOI":"10.2174\/2210681210666210108111413","volume":"11","author":"Kumar V.","year":"2021","unstructured":"Kumar V.; Rathor S.; Overactive Bladder (OAB) Management: An Overview and Scope of Nano Drug Carriers. Nanosci Nanotechnol Asia  2021,11(6),e080121190007","journal-title":"Nanosci Nanotechnol Asia"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jconrel.2004.03.026","volume":"97","author":"Sant V.P.","year":"2004","unstructured":"Sant V.P.; Smith D.; Leroux J.C.; Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization. J Control Release  2004,97(2),301-312","journal-title":"J Control Release"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/wnan.1329","volume":"7","author":"DiSanto R.M.","year":"2015","unstructured":"DiSanto R.M.; Subramanian V.; Gu Z.; Recent advances in nanotechnology for diabetes treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol  2015,7(4),548-564","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2011.09.064","volume":"158","author":"Dash T.K.","year":"2012","unstructured":"Dash T.K.; Konkimalla V.B.; Poly-\u0454-caprolactone based formulations for drug delivery and tissue engineering: A review. J Control Release  2012,158(1),15-33","journal-title":"J Control Release"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.3109\/10717544.2014.991001","volume":"23","author":"Rai V.K.","year":"2016","unstructured":"Rai V.K.; Mishra N.; Agrawal A.K.; Jain S.; Yadav N.P.; Novel drug delivery system: An immense hope for diabetics. Drug Deliv  2016,23(7),2371-2390","journal-title":"Drug Deliv"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/pharmaceutics13040503","volume":"13","author":"Craparo E.F.","year":"2021","unstructured":"Craparo E.F.; Cabibbo M.; Conigliaro A.; Barreca M.M.; Musumeci T.; Giammona G.; Cavallaro G.; Rapamycin-loaded polymeric nanoparticles as an advanced formulation for macrophage targeting in atherosclerosis. Pharmaceutics  2021,13(4),503","journal-title":"Pharmaceutics"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"102417","DOI":"10.1016\/j.nano.2021.102417","volume":"37","author":"Di Trani N.","year":"2021","unstructured":"Di Trani N.; Liu H.C.; Qi R.; Viswanath D.I.; Liu X.; Chua C.Y.X.; Grattoni A.; Long-acting tunable release of amlodipine loaded PEG-PCL micelles for tailored treatment of chronic hypertension. Nanomedicine  2021,37,102417","journal-title":"Nanomedicine"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2019.05.047","volume":"566","author":"Mart\u00edn Gim\u00e9nez V.M.","year":"2019","unstructured":"Mart\u00edn Gim\u00e9nez V.M.; D\u00edaz-Rodr\u00edguez P.; Sanz R.L.; Vivero-Lopez M.; Concheiro A.; Diez E.; Prado N.; Enrique Kassuha D.; Alvarez-Lorenzo C.; Manucha W.; Anandamide-nanoformulation obtained by electrospraying for cardiovascular therapy. Int J Pharm  2019,566,1-10","journal-title":"Int J Pharm"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3109\/10717544.2016.1165314","volume":"23","author":"Mishra A.","year":"2016","unstructured":"Mishra A.; Imam S.S.; Aqil M.; Ahad A.; Sultana Y.; Ameeduzzafar; Ali, A. Carvedilol nano lipid carriers: Formulation, characterization and in-vivo evaluation. Drug Deliv  2016,23(4),1486-1494","journal-title":"Drug Deliv"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"43915","DOI":"10.1039\/D0RA07218D","volume":"10","author":"Hajba-Horv\u00e1th E.","year":"2020","unstructured":"Hajba-Horv\u00e1th E.; Bir\u00f3 E.; Mirank\u00f3 M.; Fodor-Kardos A.; Trif L.; Feczk\u00f3 T.; Preparation and in vitro characterization of valsartan-loaded ethyl cellulose and poly(methyl methacrylate) nanoparticles. RSC Advances  2020,10(72),43915-43926","journal-title":"RSC Advances"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijpharm.2008.10.016","volume":"369","author":"Plumley C.","year":"2009","unstructured":"Plumley C.; Gorman E.M.; El-Gendy N.; Bybee C.R.; Munson E.J.; Berkland C.; Nifedipine nanoparticle agglomeration as a dry powder aerosol formulation strategy. Int J Pharm  2009,369(1-2),136-143","journal-title":"Int J Pharm"},{"key":"ref=106","first-page":"1","volume":"60","author":"Kumar L.","year":"2020","unstructured":"Kumar L.; Rapidly dissolving Felodipine nanoparticle strips-formulation using design of experiment and characterisation. J Drug Deliv Sci Technol  2020,60,1-5","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"102210","DOI":"10.1016\/j.jddst.2020.102210","volume":"61","author":"Al Ashmawy A.Z.G.","year":"2021","unstructured":"Al Ashmawy A.Z.G.; Eissa N.G.; El Nahas H.M.; Balata G.F.; Fast disintegrating tablet of Doxazosin Mesylate nanosuspension: Preparation and characterization. J Drug Deliv Sci Technol  2021,61,102210","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jddst.2018.03.011","volume":"45","author":"\u00d6zdemir S.","year":"2018","unstructured":"\u00d6zdemir S.; \u00c7elik B.; T\u00fcrk\u00f6z Acar E.; Duman G.; \u00dcner M.; Eplerenone nanoemulsions for treatment of hypertension. Part I: Experimental design for optimization of formulations and physical characterization. J Drug Deliv Sci Technol  2018,45,357-366","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0939-6411(98)00015-0","volume":"46","author":"Leroueil-Le Verger M.","year":"1998","unstructured":"Leroueil-Le Verger M.; Fluckiger L.; Kim Y.I.; Hoffman M.; Maincent P.; Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm  1998,46(2),137-143","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11696-020-01289-w","volume":"75","author":"Shrimal P.","year":"2021","unstructured":"Shrimal P.; Jadeja G.; Patel S.; Microfluidics nanoprecipitation of telmisartan nanoparticles: Effect of process and formulation parameters. Chem Pap  2021,75(1),205-214","journal-title":"Chem Pap"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.powtec.2016.10.068","volume":"305","author":"Fu Q.","year":"2017","unstructured":"Fu Q.; Ma M.; Li M.; Wang G.; Guo M.; Li J.; Hou Y.; Fang M.; Improvement of oral bioavailability for nisoldipine using nanocrystals. Powder Technol  2017,305,757-763","journal-title":"Powder Technol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"104796","DOI":"10.1016\/j.phrs.2020.104796","volume":"157","author":"Li J.","year":"2020","unstructured":"Li J.; Chen B.; Yu T.; Guo M.; Zhao S.; Zhang Y.; Jin C.; Peng X.; Zeng J.; Yang J.; Song X.; An efficient controlled release strategy for hypertension therapy: Folate-mediated lipid nanoparticles for oral peptide delivery. Pharmacol Res  2020,157,104796","journal-title":"Pharmacol Res"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijpharm.2015.01.003","volume":"479","author":"Summerlin N.","year":"2015","unstructured":"Summerlin N.; Soo E.; Thakur S.; Qu Z.; Jambhrunkar S.; Popat A.; Resveratrol nanoformulations: Challenges and opportunities. Int J Pharm  2015,479(2),282-290","journal-title":"Int J Pharm"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.lfs.2017.11.046","volume":"193","author":"Hassanzadeh P.","year":"2018","unstructured":"Hassanzadeh P.; Arbabi E.; Atyabi F.; Dinarvand R.; Ferulic acid-loaded nanostructured lipid carriers: A promising nanoformulation against the ischemic neural injuries. Life Sci  2018,193,64-76","journal-title":"Life Sci"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s40005-017-0324-x","volume":"48","author":"Manchanda S.","year":"2018","unstructured":"Manchanda S.; Sahoo P.K.; Fabrication and characterization of mucoadhesive topical nanoformulations of dorzolamide HCl for ocular hypertension. J Pharm Investig  2018,48(3),323-332","journal-title":"J Pharm Investig"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2174\/1573402117666210921121622","volume":"18","author":"Mohammadipour F.","year":"2022","unstructured":"Mohammadipour F.; Kiani A.; Amin A.; The high potency of polymeric nanoparticles in the drug delivery system for hypertension treatment: A systematic review. Curr Hypertens Rev  2022,18(1),54-63","journal-title":"Curr Hypertens Rev"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"e110621194025","DOI":"10.2174\/1573403X17666210611115823","volume":"18","author":"Moradifar N.","year":"2022","unstructured":"Moradifar N.; Kiani A.A.; Veiskaramian A.; Karami K.; Role of organic and inorganic nanoparticles in the drug delivery system for hypertension treatment: A systematic review. Curr Cardiol Rev  2022,18(1),e110621194025","journal-title":"Curr Cardiol Rev"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/genes13081394","volume":"13","author":"Masilela C.","year":"2022","unstructured":"Masilela C.; Adeniyi O.V.; Benjeddou M.; Single nucleotide polymorphisms in amlodipine-associated genes and their correlation with blood pressure control among south african adults with hypertension. Genes  2022,13(8),1394","journal-title":"Genes"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"101","DOI":"10.22270\/jddt.v11i4.4865","volume":"11","author":"Pawar K.","year":"2021","unstructured":"Pawar K.; Kachave R.; Kanawade M.; Zagre V.; A review on nanoparticles drug delivery system. J Drug Deliv Ther  2021,11(4),101-104","journal-title":"J Drug Deliv Ther"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/HYPERTENSIONAHA.118.12005","volume":"73","author":"Fancher I.S.","year":"2019","unstructured":"Fancher I.S.; Rubinstein I.; Levitan I.; Potential strategies to reduce blood pressure in treatment-resistant hypertension using food and drug administration\u2013approved nanodrug delivery platforms. Hypertension  2019,73(2),250-257","journal-title":"Hypertension"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010291414240322112508","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/228530\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010291414240322112508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T07:09:06Z","timestamp":1733728146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/228530\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":120,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010291414240322112508","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-11-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}